CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-280

[Back in Oz]

For what is worth, Stonks92 post triggered a good conversation, but quite frankly he hasn’t given a single value or decent explanation of why this is overvalued.

I don't think I need to add anything else since many factors have been covered above, but in relative terms, and let's assume EYE is indeed overvalued, it means that SGHT is way overvalued since all the fundamentals in EYE are way better than SGHT's.

Where I'm going to is that SGHT is slowing it's sales rate, while EYE is still growing (Fast or Slow is in the eye [] of the beholder) so my view is that EYE still needs to catch up a bit with SGHT in MC at the very least. Let alone how good EYE’s product is in comparison with SGHT’s.

My order got filled at 0.215... impressed with the volume today.

Seems like the global tailwinds hitting, hopefully doesn’t go too much far down from here.

GLTAH.